Disclosed are compounds of general formula (I), their stereoisomers, regioisomers, tautomeric forms and novel intermediates involved in their synthesis, their pharmaceutically acceptable salts. These compounds are suitable as Poly (ADP-ribose) polymerase- 1 inhibitors (PARP-1 inhibitors).
本发明涉及一般式(I)的化合物,它们的立体异构体,区域异构体,互变异构体和其合成中所涉及的新型中间体,以及其药学上可接受的盐。这些化合物适用于作为聚(
ADP核糖)聚合酶-1
抑制剂(PARP-1
抑制剂)。